Thales (HO) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Achieved strong commercial momentum in H1 2024, with order intake up 26% to €10.8 billion and backlog at a record €47 billion, driven by large defense and security orders.
Sales grew 8.9% in real terms (6% organically) to €9.5 billion, with robust performance in Aeronautics and Defense & Security.
EBIT margin improved to 11.5%, and adjusted net income rose 6% to €866 million, despite higher R&D and financial expenses.
Completed Cobham Aerospace acquisition and finalized disposal of transport activity.
Free operating cash flow from continuing operations was €23 million, reflecting higher working capital needs.
Financial highlights
Order intake reached €10.8 billion, book-to-bill ratio at 1.13, supported by 12 large orders, including three over €500 million.
Sales at €9.5 billion, up 8.9% in real terms and 6% organically, with Aeronautics showing double-digit growth and Defense & Security high single-digit growth.
EBIT up 10.4% to €1,096 million, margin at 11.5% vs. 11.4% last year; gross margin hit 29.2% of sales.
Adjusted EPS at €4.21, up 7.7% year-over-year.
Net debt increased to €4,594 million at June 2024, mainly due to acquisitions, dividends, and share buybacks.
Outlook and guidance
Organic sales growth guidance raised to 5–6%, targeting €19.9–20.1 billion in sales for 2024.
EBIT margin expected to improve to 11.7–11.8% for 2024.
Book-to-bill ratio expected to remain above 1, with strong commercial performance anticipated.
Free cash flow conversion ratio close to 100% of adjusted net income for the full year, excluding transport.
Space business EBIT margin expected to be negative for the full year due to lower telecom activity, high R&D, and restructuring costs.
Latest events from Thales
- Record sales, cash flow, and profitability in 2025, with strong 2026 growth guidance.HO
Q4 20253 Mar 2026 - Order intake up 23% organically and sales up 6.2%, with 2024 guidance confirmed and strong defense growth.HO
Q3 202419 Jan 2026 - Targets €25B+ revenue and 13–14% EBIT margin by 2028, leveraging tech, premiumization, and ESG.HO
Investor Day 202414 Jan 2026 - Record orders, strong sales, and higher margins drive robust 2024 results and 2025 outlook.HO
Q4 20247 Jan 2026 - Q1 2025 saw strong sales growth and a solid outlook, despite lower order intake.HO
Q1 202520 Dec 2025 - Sales and margins rose strongly, prompting an upgraded 2025 growth outlook.HO
Q2 20256 Nov 2025 - Order intake and sales up 9% organically, with 2025 guidance confirmed and strong Defence growth.HO
Q3 202523 Oct 2025